Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

GTHRX vs. XLV: which is better?

Bottom line

GTHRX vs XLV: the short answer

GTHRX (INVESCO Health Care Fund) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both mutual funds.

XLV is cheaper at 0.08% vs 1.32% — a difference of $124 a year per $10,000 invested.

Over five years, XLV returned +8.1% a year vs +3.5% for GTHRX.

Updated Nov 19, 2026

GTHRX vs XLV side by side

GTHRXXLV
TypeMutual fundETF
Fund familyInvescoSPDR (State Street)
CategoryHealth Care SectorHealth Care Sector
Expense ratio1.32%0.08%
Annual cost per $10k$132$8
10-yr cost on $10k (prospectus)$1,590$103
Max front load0%None
12b-1 fee0.5%0.02%
1-yr return+15.2%+14.5%
5-yr return (annualized)+3.5%+8.1%
10-yr return (annualized)+6.1%+9.8%
Best quarter+19.6%+14.5%
Worst quarter−16.5%−12.7%
Net assets (fund)$1.2B$40.6B
Number of holdings8265
Portfolio turnover59%2%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearGTHRXXLVDifference
2024+4.0%+2.5%+1.5%
2023+3.1%+2.0%+1.1%
2022−13.5%−2.1%−11.5%
2021+12.2%+25.9%−13.7%
2020+14.5%+13.3%+1.2%
2019+32.0%+20.7%+11.3%
2018+0.5%+6.3%−5.8%
2017+15.5%+21.7%−6.2%
2016−11.7%−2.8%−8.9%

Source: Fund prospectus bar charts

Holdings overlap

10 of GTHRX's top 25 holdings also appear in XLV's top 25.

Shared top holdings
HoldingGTHRXXLV
Eli Lilly and Co.10.59%16.51%
Johnson & Johnson6.76%10.64%
UnitedHealth Group Inc.6.17%6.57%
Merck & Co., Inc.4.59%5.52%
AbbVie Inc.4.03%7.74%
Gilead Sciences, Inc.3.63%2.73%
CVS Health Corp.2.52%2.30%
Cardinal Health, Inc.2.10%0.97%
Vertex Pharmaceuticals Inc.2.01%2.19%
Thermo Fisher Scientific Inc.1.55%3.24%

Source: SEC Form N-PORT

GTHRX top 10

  1. Eli Lilly and Co. — 10.59%
  2. Johnson & Johnson — 6.76%
  3. UnitedHealth Group Inc. — 6.17%
  4. Invesco Private Prime Fund — 4.67%
  5. Merck & Co., Inc. — 4.59%
  6. AbbVie Inc. — 4.03%
  7. Gilead Sciences, Inc. — 3.63%
  8. argenx SE — 3.24%
  9. CVS Health Corp. — 2.52%
  10. Welltower Inc. — 2.34%

XLV top 10

  1. Eli Lilly & Co — 16.51%
  2. Johnson & Johnson — 10.64%
  3. AbbVie Inc — 7.74%
  4. UnitedHealth Group Inc — 6.57%
  5. Merck & Co Inc — 5.52%
  6. Amgen Inc — 3.40%
  7. Thermo Fisher Scientific Inc — 3.24%
  8. Abbott Laboratories — 2.75%
  9. Gilead Sciences Inc — 2.73%
  10. Intuitive Surgical Inc — 2.45%

FAQ

What is the difference between GTHRX and XLV?
GTHRX (INVESCO Health Care Fund) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both mutual funds. XLV is cheaper at 0.08% vs 1.32% — a difference of $124 a year per $10,000 invested.
Which is cheaper, GTHRX or XLV?
XLV has the lower expense ratio (0.08%).
Should I own both GTHRX and XLV?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.